Page last updated: 2024-09-04

13,14-dihydroprostaglandin e1 and dinoprostone

13,14-dihydroprostaglandin e1 has been researched along with dinoprostone in 2 studies

Compound Research Comparison

Studies
(13,14-dihydroprostaglandin e1)
Trials
(13,14-dihydroprostaglandin e1)
Recent Studies (post-2010)
(13,14-dihydroprostaglandin e1)
Studies
(dinoprostone)
Trials
(dinoprostone)
Recent Studies (post-2010) (dinoprostone)
272329,1051,3466,357

Protein Interaction Comparison

ProteinTaxonomy13,14-dihydroprostaglandin e1 (IC50)dinoprostone (IC50)
Prostaglandin E2 receptor EP1 subtypeHomo sapiens (human)0.0155
Prostaglandin E2 receptor EP4 subtypeHomo sapiens (human)0.0031
Prostaglandin E2 receptor EP4 subtypeRattus norvegicus (Norway rat)0.0021
Prostaglandin E2 receptor EP3 subtypeHomo sapiens (human)0.002
Prostaglandin E2 receptor EP2 subtypeHomo sapiens (human)0.0087
Prostacyclin receptorHomo sapiens (human)0.26
Prostaglandin E2 receptor EP2 subtypeRattus norvegicus (Norway rat)0.0052

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, TL; Sharif, NA1
Hesse, WH; Peskar, BA; Rudofsky, G1

Other Studies

2 other study(ies) available for 13,14-dihydroprostaglandin e1 and dinoprostone

ArticleYear
Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor.
    British journal of pharmacology, 2000, Volume: 130, Issue:8

    Topics: Binding, Competitive; Cell Line; Cell Membrane; Dinoprostone; DNA, Recombinant; Dose-Response Relationship, Drug; Humans; Ligands; Prostaglandins; Radioligand Assay; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Tritium

2000
[Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease].
    Wiener klinische Wochenschrift, 1991, Volume: 103, Issue:18

    Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Arterial Occlusive Diseases; Biotransformation; Dinoprostone; Female; Humans; Infusions, Intravenous; Male; Middle Aged

1991